Sekisui Chemical Group and Himawari no Kai Begin Collaboration
NQ Score
70/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Sekisui Medical, part of Sekisui Chemical Group, and NPO Himawari no Kai have started a collaboration to promote understanding of expanded newborn screening through accurate information dissemination.
AI Analysis
Frequently Asked Questions
- Q: What diseases does expanded newborn screening cover?
- A: Primary immunodeficiency, spinal muscular atrophy, lysosomal storage diseases, etc.
- Q: Where can the test be taken?
- A: At affiliated medical institutions. Contact Sekisui Medical or Himawari no Kai.
- Q: How much does it cost?
- A: Varies by municipality; the collaboration aims for public funding.